Figure 2.

Impact of the timed daily bromocriptine (at ZT 13 or ZT 19) or control treatment for 16 days on metabolic syndrome parameters. Effects were examined using 1-way ANOVA (F) followed by pairwise post hoc (Holm–Sidak method) for normally distributed data, or Kruskal–Wallis (H) one-way analysis of variance on ranks test followed by Dunn’s pairwise multiple comparison procedures test for non-normal data, see Methods. Significant pairwise comparisons revealed from post hoc analysis or Dunn’s test are indicated by horizontal bars with *—p < 0.05, 2-sided; †—p < 0.05, 1-sided (see Results for details of individual parameter comparison p values).